Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.10, pp.721-732, 2021 (SCI-Expanded)
Article / Article
ANATOLIAN JOURNAL OF CARDIOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival, COMBINATION THERAPY, ORAL SILDENAFIL, TARGETED DRUGS, NITRIC-OXIDE, PROSTACYCLIN, METAANALYSIS, INSIGHTS
Bursa Uludag University Affiliated:
Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).